ROBERT FIELDING: Open Payments
NPI 1477152353 · SIMI VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,351 in 72 payments from 16 companies in 2025. Trend: 2023 $1,144 · 2024 $1,362 · 2025 $1,351
Food & beverage: $1,351
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $295 |
| AstraZeneca Pharmaceuticals LP | 9 | $174 |
| Lilly USA, LLC | 8 | $169 |
| ABBVIE INC. | 9 | $160 |
| Amgen Inc. | 10 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $115 |
| Dexcom, Inc. | 3 | $56 |
| PFIZER INC. | 2 | $37 |
| Sage Therapeutics, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $33 |
Products named: MOUNJARO, AIRSUPRA, JARDIANCE, Wegovy, OTEZLA, Ozempic, VRAYLAR, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
